Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
bezuclastinib (PLX9486)
i
Other names:
PLX9486, PLX 9486, CGT9486, CGT-9486, PLX-9486, CGT 9486
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Cogent Biosci, Daiichi Sankyo
Drug class:
c-KIT inhibitor
Related drugs:
‹
dasatinib (215)
imatinib (166)
sunitinib (139)
lenvatinib (90)
YD312 (21)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
flumatinib (5)
ABT-869 (2)
AG-1296 (1)
IDRX-42 (1)
OSI-930 (1)
MP470 (1)
CS 2164 (1)
E7050 (1)
CDX-0158 (0)
M4205 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
AER-901 (0)
TSU-68 (0)
BAY 57- 9352 (0)
PTK787 (0)
dasatinib (215)
imatinib (166)
sunitinib (139)
lenvatinib (90)
YD312 (21)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
flumatinib (5)
ABT-869 (2)
AG-1296 (1)
IDRX-42 (1)
OSI-930 (1)
MP470 (1)
CS 2164 (1)
E7050 (1)
CDX-0158 (0)
M4205 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
AER-901 (0)
TSU-68 (0)
BAY 57- 9352 (0)
PTK787 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
KIT mutation
Gastrointestinal Stromal Tumor
KIT mutation
Gastrointestinal Stromal Tumor
sunitinib + PLX9486
Sensitive: C3 – Early Trials
sunitinib + PLX9486
Sensitive
:
C3
sunitinib + PLX9486
Sensitive: C3 – Early Trials
sunitinib + PLX9486
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login